Skip to content

Clinical study of He's yulin prescription combined with Dumai fumigation on kidney deficiency and blood stasis type RIF

Clinical study of He's yulin prescription combined with Dumai fumigation on kidney deficiency and blood stasis type RIF

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061616
Enrollment
Unknown
Registered
2022-06-29
Start date
2020-09-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent implantation failure

Interventions

Chinese medicine combined with fumigation group:He's yulin prescription for oral administration
control group:Aspirin orally

Sponsors

Ningbo Women and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnostic criteria; 2. Aged 20-45 years; 3. Patients who agree to adhere to the oral treatment of traditional Chinese medicine and fumigation of traditional Chinese medicine.

Exclusion criteria

Exclusion criteria: 1. Male infertility; 2. Chromosomal abnormality infertility, immune infertility; 3. Abnormal uterine morphology, such as uterine malformation, mediastinal uterus, uterine submucosal fibroids, and severe intrauterine adhesion; 4. Ovulatory dysfunction infertility such as premature ovarian failure, polycystic ovary syndrome and hyperprolactinemia; 5. Patients with thyroid, adrenal, pituitary and other organic diseases and endocrine diseases resulting in infertility; 6. Ssexually transmitted diseases or acute inflammatory reactions of the genitourinary system; 7. Complicated with serious systemic diseases such as heart, liver, kidney and hematopoietic system; 8. Persons with serious mental or psychological diseases who cannot cooperate with treatment.

Design outcomes

Primary

MeasureTime frame
Endometrial thickness;Endometrial blood flow;Uterine arterial blood flow;Clinical symptoms;

Countries

China

Contacts

Public ContactHuang Yueying
34234119@qq.com+86 13867859636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026